Methicillin-resistant staphylococcus aureus prevention strategies in the ICU: A clinical decision analysis

Critical Care Medicine

Volumn 43, Issue 2, 2015, Pages 382-393

  Ziakas, Panayiotis D ^a,b   Zacharioudakis, Ioannis M ^a,b   Zervou, Fainareti N ^a,b   Mylonakis, Eleftherios ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Cost effectiveness; Infection; Intensive care; Methicillin resistant; Methicillin resistant staphylococcus aureus

Indexed keywords

CHLORHEXIDINE GLUCONATE; PSEUDOMONIC ACID;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; COST EFFECTIVENESS ANALYSIS; DECISION TREE; DRUG COST; FEMALE; HEALTH CARE POLICY; HOSPITAL DISCHARGE; HOSPITAL RUNNING COST; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; PRIORITY JOURNAL; PROGRAM ACCEPTABILITY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SCREENING; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; SURVIVAL; COST BENEFIT ANALYSIS; CROSS INFECTION; ECONOMICS; HETEROZYGOTE; PROCEDURES; STAPHYLOCOCCAL INFECTIONS; STATISTICAL MODEL;

CARRIER STATE; COST-BENEFIT ANALYSIS; CROSS INFECTION; DECISION TREES; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, ECONOMIC; QUALITY-ADJUSTED LIFE YEARS; STAPHYLOCOCCAL INFECTIONS;

EID: 84925361778     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000711     Document Type: Article

References (39)

1. Sievert DM, Ricks P, Edwards JR, et al; National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013; 34:1-14.
2. Ziakas PD, Anagnostou T, Mylonakis E: The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU setting: A meta-analysis of published studies. Crit Care Med 2014; 42:433-444.
3. Huang SS, Septimus E, Kleinman K, et al; CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program: Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368:2255-2265.
4. Weinstein F, Fineberg HV: Clinical Decision Analysis. Philadelphia, PA, WB Saunders, 1980.
5. Ziakas PD, Karsaliakos P, Mylonakis E: Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: A meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance. Haematologica 2009; 94:998-1005.
6. Robotham JV, Graves N, Cookson BD, et al: Screening, isolation, and decolonisation strategies in the control of methicillin resistant Staphylococcus aureus in intensive care units: Cost effectiveness evaluation. BMJ 2011; 343:d5694.
7. Barnett AG, Batra R, Graves N, et al: Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit. Am J Epidemiol 2009; 170:1186-1194.
8. Courville XF, Tomek IM, Kirkland KB, et al: Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: A cost-effectiveness analysis. Infect Control Hosp Epidemiol 2012; 33:a.
9. Ritz J, Pashnik B, Padula C, et al: Effectiveness of 2 methods of chlorhexidine bathing. J Nurs Care Qual 2012; 27:171-175.
10. U.S. Department of Labor, Bureau of Labor Statistics: Occupational Employment Statistics. Available at: Http://www.bls.gov/oes/current/naics4-622100.htm#29-0000. Accessed October 25, 2013.
11. Harris AD, Pineles L, Belton B, et al; Benefits of Universal Glove and Gown (BUGG) Investigators: Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: A randomized trial. JAMA 2013; 310:1571-1578.
12. Spence MR, Dammel T, Courser S: Contact precautions for methicillin- resistant Staphylococcus aureus colonization: Costly and unnecessary? Am J Infect Control 2012; 40:535-538.
13. Dasta JF, McLaughlin TP, Mody SH, et al: Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med 2005; 33:1266-1271.
14. Kluytmans J, Harbarth S: Methicillin-resistant Staphylococcus aureus decolonization: "Yes, we can, " but will it help? Infect Control Hosp Epidemiol 2009; 30:633-635.
15. van Rijen M, Bonten M, Wenzel R, et al: Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008; 4:CD006216.
16. Simor AE, Phillips E, McGeer A, et al: Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication ofmethicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007; 44:178-185.
17. U.S. Department of Labor, Bureau of Labor Statistics: Consumer Price Index. Available at: Http://www.bls.gov/news.release/cpi.toc.htm. Accessed November 7, 2013.
18. Cuthbertson BH, Roughton S, Jenkinson D, et al: Quality of life in the five years after intensive care: A cohort study. Crit Care 2010; 14:R6.
19. Williams TA, Dobb GJ, Finn JC, et al: Determinants of long-term survival after intensive care. Crit Care Med 2008; 36:1523-1530.
20. U.S. Census Bureau, Statistical Abstract of the United States, 2012: Table 107. Available at: Http://www.census.gov/compendia/statab/2012/tables/12s0107.pdf Accessed November 7, 2013.
21. Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5:13.
22. Fenwick E, O'Brien BJ, Briggs A: Cost-effectiveness acceptability curves-Facts, fallacies and frequently asked questions. Health Econ 2004; 13:405-415.
23. Fenwick E, Claxton K, Sculpher M: Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ 2001; 10:779-787.
24. Tübbicke A, Hübner C, Hübner NO, et al: Cost comparison of MRSA screening and management-A decision tree analysis. BMC Health Serv Res 2012; 12:438.
25. Nelson RE, Samore MH, Smith KJ, et al: Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect 2010; 16:1740-1746.
26. Halpern NA, Pastores SM: Critical care medicine in the United States 2000-2005: An analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med 2010; 38:65-71.
27. U.S Department of Health and Human Services: The Critical Care Workforce. Available at: Http://bhpr.hrsa.gov/healthworkforce/reports/studycriticalcarephys.pdf. Accessed November 7, 2013.
28. Groeger JS, Strosberg MA, Halpern NA, et al: Descriptive analysis of critical care units in the United States. Crit Care Med 1992; 20:846-863.
29. Orsini J, Butala A, Ahmad N, et al: Factors influencing triage decisions in patients referred for ICU admission. J Clin Med Res 2013; 5:343-349.
30. Zacharioudakis IM, Zervou FN, Ziakas PD, et al: Meta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients. J Am Soc Nephrol 2014; 25:2131-2141.
31. Ziakas PD, Pliakos EE, Zervou FN, et al: MRSA and VRE colonization in solid organ transplantation: A meta-analysis of published studies. Am J Transplant 2014; 14:1887-1894.
32. Robicsek A, Beaumont JL, Thomson RB Jr, et al: Topical therapy for methicillin-resistant Staphylococcus aureus colonization: Impact on infection risk. Infect Control Hosp Epidemiol 2009; 30:623-632.
33. Harbarth S, Dharan S, Liassine N, et al: Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43:1412-1416.
34. Fritz SA, Hogan PG, Camins BC, et al: Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with communityonset skin and soft tissue infections. Antimicrob Agents Chemother 2013; 57:559-568.
35. Batra R, Cooper BS, Whiteley C, et al: Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010; 50:210-217.
36. Pittet D, Hugonnet S, Harbarth S, et al: Effectiveness of a hospitalwide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000; 356:1307-1312.
37. Derde LP, Cooper BS, Goossens H, et al; MOSAR WP3 Study Team: Interventions to reduce colonisation and transmission of antimicrobialresistant bacteria in intensive care units: An interrupted time series study and cluster randomised trial. Lancet Infect Dis 2014; 14:31-39.
38. Climo MW, Yokoe DS, Warren DK, et al: Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368:533-542.
39. Schweickert B, Geffers C, Farragher T, et al: The MRSA-import in ICUs is an important predictor for the occurrence of nosocomial MRSA cases. Clin Microbiol Infect 2011; 17:901-906.